Dr. Svetlana Meier is a rheumatologist in Meridian,Idaho.
Female
1609054659
Description | # of Times Performed | # of Patients | Average Charge ($) |
---|---|---|---|
Aspiration and/or injection of small joint or joint capsule with recording and reporting using ultrasound guidance | 21.0 | 13.0 | 138.0 |
Aspiration and/or injection of intermediate joint or joint capsule with recording and reporting using ultrasound guidance | 19.0 | 14.0 | 153.0 |
Aspiration and/or injection of major joint or joint capsule with recording and reporting using ultrasound guidance | 100.0 | 70.0 | 175.0 |
Insertion of needle into vein for collection of blood sample | 987.0 | 441.0 | 15.0 |
Complete ultrasound of joint of arm or leg | 205.0 | 91.0 | 300.0 |
Blood test, comprehensive group of blood chemicals | 945.0 | 435.0 | 30.0 |
Acute hepatitis panel | 89.0 | 85.0 | 120.0 |
Manual urinalysis test with examination using microscope | 18.0 | 18.0 | 20.0 |
Automated urinalysis test | 34.0 | 33.0 | 15.0 |
Vitamin D-3 level | 195.0 | 182.0 | 85.0 |
Creatine kinase (cardiac enzyme) level | 88.0 | 81.0 | 20.0 |
Measurement of substance using immunoassay technique | 148.0 | 79.0 | 30.0 |
Parathormone (parathyroid hormone) level | 62.0 | 62.0 | 110.0 |
Thyroxine (thyroid chemical) measurement | 21.0 | 21.0 | 35.0 |
Blood test, thyroid stimulating hormone (TSH) | 94.0 | 92.0 | 40.0 |
Uric acid level, blood | 127.0 | 113.0 | 15.0 |
Complete blood cell count (red cells, white blood cell, platelets), automated test | 936.0 | 428.0 | 20.0 |
Red blood cell sedimentation rate, to detect inflammation | 939.0 | 436.0 | 10.0 |
Screening test for autoimmune disorder | 73.0 | 73.0 | 30.0 |
Measurement C-reactive protein for detection of infection or inflammation | 942.0 | 437.0 | 15.0 |
Beta 2 glycoprotein 1 antibody (autoantibody) measurement | 30.0 | 15.0 | 60.0 |
Cardiolipin antibody (tissue antibody) measurement | 32.0 | 16.0 | 60.0 |
Phospholipid antibody (autoimmune antibody) measurement | 30.0 | 15.0 | 100.0 |
Measurement of complement function (immune system proteins) | 104.0 | 51.0 | 30.0 |
Measurement of antibody for rheumatoid arthritis assessment | 84.0 | 84.0 | 40.0 |
Measurement of DNA antibody | 40.0 | 40.0 | 40.0 |
Measurement of antibody for assessment of autoimmune disorder | 277.0 | 39.0 | 55.0 |
Microsomal antibodies (autoantibody) measurement | 42.0 | 42.0 | 45.0 |
Rheumatoid factor level | 80.0 | 80.0 | 15.0 |
Tuberculosis test | 50.0 | 50.0 | 219.8 |
Thyroglobulin (thyroid protein) antibody measurement | 17.0 | 17.0 | 50.0 |
Crystal identification from tissue or body fluid | 15.0 | 13.0 | 55.0 |
Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour | 278.0 | 59.0 | 150.0 |
Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | 182.0 | 101.0 | 46.0 |
Injection of different drug or substance into a vein for therapy, diagnosis, or prevention | 40.0 | 12.0 | 40.0 |
Infusion of chemotherapy into a vein up to 1 hour | 234.0 | 46.0 | 300.0 |
Infusion of chemotherapy into a vein | 244.0 | 40.0 | 150.0 |
New patient office or other outpatient visit, typically 45 minutes | 112.0 | 112.0 | 302.0 |
Established patient office or other outpatient visit, typically 15 minutes | 71.0 | 65.0 | 133.0 |
Established patient office or other outpatient, visit typically 25 minutes | 639.0 | 377.0 | 198.0 |
Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 11200.0 | 17.0 | 73.459821429 |
Injection, denosumab, 1 mg | 9120.0 | 87.0 | 30.0 |
Injection, infliximab, excludes biosimilar, 10 mg | 9080.0 | 35.0 | 150.0 |
Injection, methylprednisolone sodium succinate, up to 125 mg | 38.0 | 12.0 | 50.0 |
Injection, tocilizumab, 1 mg | 45221.0 | 11.0 | 7.5998321576 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 718.0 | 104.0 | 10.0 |
Injection, zoledronic acid, 1 mg | 160.0 | 32.0 | 110.0 |
Injection, rituximab, 10 mg | 3000.0 | 11.0 | 160.0 |
Cookies on this website are used to improve your experience and display advertising. You agree to the use of cookies by continuing to use this website. Our Privacy Policy contains more information about how we use cookies.